DnB Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$177M Buy
725,901
+72,051
+11% +$16.8M 0.63% 25
2025
Q4
$135M Sell
653,850
-507,365
-44% -$100M 0.47% 34
2025
Q3
$215M Sell
1,161,215
-94,911
-8% -$16.3M 0.81% 22
2025
Q2
$192M Buy
1,256,126
+47,950
+4% +$7.37M 0.8% 22
2025
Q1
$200M Sell
1,208,176
-116,849
-9% -$18.3M 0.92% 17
2024
Q4
$192M Sell
1,325,025
-37,923
-3% -$5.88M 0.83% 19
2024
Q3
$221M Buy
1,362,948
+4,910
+0.4% +$782K 1% 13
2024
Q2
$198M Buy
1,358,038
+144,056
+12% +$21.4M 0.95% 19
2024
Q1
$192M Sell
1,213,982
-140,085
-10% -$22.3M 1% 18
2023
Q4
$212M Buy
1,354,067
+16,186
+1% +$2.48M 1.1% 15
2023
Q3
$208M Sell
1,337,881
-111,322
-8% -$18.4M 1.24% 13
2023
Q2
$240M Sell
1,449,203
-3,945
-0.3% -$637K 1.38% 10
2023
Q1
$225M Sell
1,453,148
-73,267
-5% -$11.8M 1.43% 10
2022
Q4
$270M Buy
1,526,415
+19,330
+1% +$3.34M 1.9% 7
2022
Q3
$246M Sell
1,507,085
-58,139
-4% -$9.84M 1.9% 7
2022
Q2
$278M Sell
1,565,224
-4,495
-0.3% -$801K 1.95% 7
2022
Q1
$278M Buy
1,569,719
+31,902
+2% +$5.43M 1.65% 8
2021
Q4
$263M Buy
1,537,817
+63,417
+4% +$10.4M 1.54% 11
2021
Q3
$238M Sell
1,474,400
-82,524
-5% -$14.1M 1.55% 12
2021
Q2
$256M Buy
1,556,924
+50,742
+3% +$8.4M 1.7% 10
2021
Q1
$248M Sell
1,506,182
-123,430
-8% -$20M 1.81% 9
2020
Q4
$256M Buy
1,629,612
+136
+0% +$20.1K 2.25% 8
2020
Q3
$243M Buy
1,629,476
+112,659
+7% +$16.7M 2.58% 7
2020
Q2
$213M Buy
1,516,817
+35,272
+2% +$5.14M 2.51% 8
2020
Q1
$194M Buy
1,481,545
+125,912
+9% +$17.9M 2.86% 5
2019
Q4
$198M Sell
1,355,633
-504,917
-27% -$68.5M 1.94% 6
2019
Q3
$241M Buy
1,860,550
+113,527
+6% +$15M 2.72% 4
2019
Q2
$243M Buy
1,747,023
+190,988
+12% +$26.4M 2.8% 6
2019
Q1
$218M Sell
1,556,035
-8,413
-0.5% -$1.13M 2.48% 7
2018
Q4
$202M Buy
1,564,448
+243,578
+18% +$34M 2.62% 6
2018
Q3
$183M Buy
1,320,870
+263,436
+25% +$35M 2.05% 8
2018
Q2
$128M Buy
1,057,434
+84,800
+9% +$10.6M 1.51% 11
2018
Q1
$125M Buy
972,634
+122,455
+14% +$16.6M 1.5% 13
2017
Q4
$119M Sell
850,179
-366,012
-30% -$51M 1.43% 15
2017
Q3
$158M Buy
1,216,191
+19,800
+2% +$2.62M 2.1% 9
2017
Q2
$158M Sell
1,196,391
-108,634
-8% -$13.9M 2.31% 7
2017
Q1
$163M Buy
1,305,025
+15,600
+1% +$1.86M 2.55% 6
2016
Q4
$149M Buy
1,289,425
+84,700
+7% +$9.78M 2.73% 4
2016
Q3
$141M Buy
1,204,725
+46,300
+4% +$5.62M 2.77% 4
2016
Q2
$139M Buy
1,158,425
+259,600
+29% +$29.5M 2.95% 3
2016
Q1
$96.1M Sell
898,825
-54,074
-6% -$5.6M 2.01% 6
2015
Q4
$97.9M Sell
952,899
-13,830
-1% -$1.39M 2.1% 9
2015
Q3
$90.2M Sell
966,729
-300,824
-24% -$29.1M 2.25% 8
2015
Q2
$124M Buy
1,267,553
+126,540
+11% +$12.7M 2.72% 6
2015
Q1
$115M Buy
1,141,013
+315,202
+38% +$32.1M 2.56% 6
2014
Q4
$86.4M Sell
825,811
-244,862
-23% -$25.8M 1.95% 8
2014
Q3
$114M Sell
1,070,673
-137,241
-11% -$14.2M 2.51% 5
2014
Q2
$126M Buy
+1,207,914
New +$122M 2.67% 4
2013
Q4
$121M Buy
1,318,528
+2,334
+0.2% +$215K 2.84% 7
2013
Q3
$114M Sell
1,316,194
-91,075
-6% -$8.17M 3.12% 5
2013
Q2
$121M Buy
+1,407,269
New +$119M 3.58% 3

Other funds holding JNJ

DnB Asset Management's JNJ Position: Q1 2026 in Review

DnB Asset Management increased its Johnson & Johnson (JNJ) stake by 11% in Q1 2026, buying an estimated $16.8M and bringing the position to 725,901 shares worth $177M. The position accounts for 0.63% of the portfolio, ranked #25.

DnB Asset Management first reported a position in JNJ in Q2 2013 and has held it in 51 quarters since. The position peaked at $278M in Q1 2022. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • DnB Asset Management held 725,901 shares of Johnson & Johnson worth $177M as of Q1 2026.
  • DnB Asset Management bought 72,051 Johnson & Johnson shares in Q1 2026, an estimated $16.8M.
  • Johnson & Johnson made up 0.63% of DnB Asset Management's portfolio in Q1 2026, its #25 holding.
  • DnB Asset Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 51 quarters since.
  • DnB Asset Management's Johnson & Johnson position peaked at $278M in Q1 2022.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on DnB Asset Management's 13F filing for Q1 2026, filed 14 May 2026.